NEU.AX - Neuren Pharmaceuticals Limited

ASX - ASX Delayed Price. Currency in AUD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue13,9906313,1501,673
Cost of Revenue6,1015,13613,32514,132
Gross Profit7,889-4,505-10,175-12,459
Operating Expenses
Research Development----
Selling General and Administrative2,0741,5681,8421,888
Non Recurring----
Others----
Total Operating Expenses8,1756,70415,16717,252
Operating Income or Loss5,815-6,073-12,017-15,579
Income from Continuing Operations
Total Other Income/Expenses Net-2,7429,36131,433
Earnings Before Interest and Taxes5,815-6,073-12,017-15,579
Interest Expense----
Income Before Tax3,0733,288-12,014-14,146
Income Tax Expense----749
Minority Interest----
Net Income From Continuing Ops3,0733,288-12,014-13,397
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income3,0733,288-12,014-13,397
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares3,0733,288-12,014-13,397